Overview

Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of tropisetron plus risperidone in improving cognitive symptoms in Chinese people with schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Risperidone
Tropisetron